Cost-effectiveness of adding zoledronic acid to endocrine therapy in premenopausal women with hormone-responsive early breast cancer in Portugal, Spain, and Italy, based on the ABCSG-12 Study.

Contributo in Atti di convegno
Data di Pubblicazione:
2010
Tipologia CRIS:
4.1 Contributo in Atti di convegno
Keywords:
COST-EFFECTIVENESS; BREAST CANCER; ZOLEDRONIC ACID
Elenco autori:
Autori di Ateneo:
Link alla scheda completa:
https://iris.unipv.it/handle/11571/226129
Pubblicato in:
EUROPEAN JOURNAL OF CANCER. SUPPLEMENT
Journal